Product Information
INVOKAMET 150-1,000 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.5768 per EA under NDC 50458054360. Its NADAC has been published 614 times since Nov 19, 2014.
FDA first approved this application on Aug 8, 2014.
Strength
150; 1000 mg/1; mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458054360
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA204353FDA Approved
8/8/2014
On Market Since
8/8/2014
Pharmacological Classes
Price Statistics
The NADAC for INVOKAMET 150-1,000 MG TABLET has been published 614 times since Nov 19, 2014, and over the history we have for it it has risen 91.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5768 per EA |
|---|---|
| All-time high | $9.5957 (Feb 12, 2025) |
| All-time low | $4.9970 (Nov 19, 2014) |
| 52-week high | $9.5933 |
| 52-week low | $9.5666 |
| Median price | $8.3436 |
| Average price | $8.0941 |
| Largest weekly change | +9.9% (Feb 11, 2015) |
| Weeks tracked | 614 |
| Tracking since | Nov 19, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVOKAMET 150-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INVOKAMET 150-1,000 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $9.5768 per EA (NDC 50458054360), effective Aug 19, 2026.
How has the price of INVOKAMET 150-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for INVOKAMET 150-1,000 MG TABLET has risen 91.6%. It has been tracked across 614 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for INVOKAMET 150-1,000 MG TABLET?
Since Nov 19, 2014, the NADAC for INVOKAMET 150-1,000 MG TABLET has ranged from a low of $4.9970 (Nov 19, 2014) to a high of $9.5957 (Feb 12, 2025), with a median of $8.3436 per EA.
Are there cheaper alternatives to INVOKAMET 150-1,000 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INVOKAMET XR 150-1,000 MG TAB, is $9.5294 per EA — about 0% below INVOKAMET 150-1,000 MG TABLET.
Who manufactures INVOKAMET 150-1,000 MG TABLET?
INVOKAMET 150-1,000 MG TABLET (NDC 50458054360) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.